CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Phase 1/2 Recruiting
152 enrolled
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Phase 2 Recruiting
104 enrolled
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Phase 3 Recruiting
360 enrolled
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Phase 1/2 Recruiting
96 enrolled
PRAGMATIC
Phase 2 Recruiting
104 enrolled
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Phase 2 Recruiting
20 enrolled
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
50 enrolled
inMMyCAR
Phase 1 Recruiting
40 enrolled
IPAX BrIGHT
Phase 3 Recruiting
50 enrolled
MAEva-MCT
Phase NA Recruiting
190 enrolled
QUATRO-APL
Phase 3 Recruiting
150 enrolled
A New Psychotherapy Intervention for Older Cancer Patients
Phase NA Recruiting
459 enrolled
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Phase 2 Recruiting
327 enrolled
GABRINOX2
Phase 2 Recruiting
162 enrolled
RAISE
Phase 2 Recruiting
13 enrolled
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1/2 Recruiting
80 enrolled
Massage Impact on Sleep in Pediatric Oncology
Phase NA Recruiting
70 enrolled
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Phase 2/3 Recruiting
854 enrolled
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Phase 1 Recruiting
364 enrolled
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 2 Recruiting
80 enrolled
On-Trac
Phase NA Recruiting
80 enrolled
Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures
Phase NA Recruiting
20 enrolled
Peds Ethos
Phase NA Recruiting
20 enrolled
DXP-106
Phase 1 Recruiting
54 enrolled
OralAcu
Phase NA Recruiting
75 enrolled
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Phase 3 Recruiting
698 enrolled
ALCINA4
Phase NA Recruiting
2,050 enrolled
A Study of ASP3082 in Adults With Advanced Solid Tumors
Phase 1 Recruiting
681 enrolled
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Phase 1 Recruiting
220 enrolled
Tumor HI
Phase 3 Recruiting
16 enrolled
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Phase 2 Recruiting
270 enrolled
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Phase 2 Recruiting
60 enrolled
SAFE ESO
Phase 2 Recruiting
95 enrolled
MK-3475-G21
Phase 1/2 Recruiting
20 enrolled
MCMV
Phase NA Recruiting
271 enrolled
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Phase 1 Recruiting
127 enrolled
ACTengine
Phase 1/2 Recruiting
375 enrolled
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 Recruiting
24 enrolled
FASN
Phase 2 Recruiting
50 enrolled
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/2 Recruiting
90 enrolled
First in Human Study of T3P-Y058-739 (T3P)
Phase 1/2 Recruiting
100 enrolled
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
Phase 2 Recruiting
95 enrolled
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Phase 2 Recruiting
496 enrolled
ReRT
Phase NA Recruiting
1,800 enrolled
StingMark
Phase NA Recruiting
100 enrolled
UmbrellaMAX
Phase 3 Recruiting
100 enrolled
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Phase 2 Recruiting
40 enrolled
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Phase NA Recruiting
126 enrolled
NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
Phase 1/2 Recruiting
79 enrolled
A Study of JNJ-87890387 for Advanced Solid Tumors
Phase 1 Recruiting
200 enrolled